Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials

Antithrombotic Treatments in Patients with Chronic Coronary Artery Disease or Peripheral Artery Disease: A Systematic Review of Randomised Controlled Trials

Aims. Acetylsalicylic acid (ASA) is widely used for the prevention of atherothrombotic events in patients with chronic coronary artery disease (CAD) and peripheral artery disease (PAD), but the risk of vascular events remains high. We aimed at identifying randomised controlled trials (RCTs) on antit...

Full description

Saved in:

Bibliographic Details
Main Authors:	Rupert Bauersachs, Olivia Wu, Jean-Baptiste Briere, Kevin Bowrin, Katarzyna Borkowska, Anna Jakubowska, Vanessa Taieb, Mondher Toumi, Maria Huelsebeck
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Cardiovascular Therapeutics
Online Access:	http://dx.doi.org/10.1155/2020/3057168
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Efficacy and Safety of Rivaroxaban Compared with Other Therapies Used in Patients with Peripheral Artery Disease Undergoing Peripheral Revascularization: A Systematic Literature Review and Network Meta-Analysis
by: Rupert Bauersachs, et al.
Published: (2021-01-01)

Meta-analysis of real-world evidence comparing non-vitamin K antagonist oral anticoagulants with vitamin K antagonists for the treatment of patients with non-valvular atrial fibrillation
by: Craig I. Coleman, et al.
Published: (2019-01-01)

Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
by: Kevin Bowrin, et al.
Published: (2020-01-01)

Expert Recommendations on Antithrombotic Management of Peripheral Artery Disease: Perspectives from Indian Interventional Radiologists
by: Balaji Patel Kola, et al.
Published: (2025-08-01)

Estimation of the costs attributable to vitamin K antagonist treatment in patients with non-valvular atrial fibrillation from a French societal perspective
by: Pierre Levy, et al.
Published: (2019-01-01)

Peripheral Arterial Disease
by: A.T.O. Abdool-Carrim
Published: (2004-09-01)

Practical aspects of antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
by: Zh. D. Kobalava, et al.
Published: (2021-10-01)

Up-to-date potential of antithrombotic therapy in patients with coronary artery disease and diabetes
by: O. D. Ostroumova, et al.
Published: (2020-09-01)

Epigenetic Regulation of Angiogenesis in Peripheral Artery Disease
by: Naseeb Kaur Malhi, et al.
Published: (2023-11-01)

Prevalence of peripheral artery disease in young coronary artery disease patients
by: Medikonda Malla Reddy, et al.
Published: (2024-09-01)

Endothelial Dysfunction of Patients with Peripheral Arterial Disease Measured by Peripheral Arterial Tonometry
by: Kimihiro Igari, et al.
Published: (2016-01-01)

The Completeness of Intervention Descriptions in Randomised Trials of Supervised Exercise Training in Peripheral Arterial Disease.
by: Garry A Tew, et al.
Published: (2016-01-01)

Characteristics of doctor-shoppers: a systematic literature review
by: Małgorzata Biernikiewicz, et al.
Published: (2019-01-01)

Moyamoya Disease with Peripheral Pulmonary Artery Stenoses and Coronary Artery Fistulae
by: Lindsay Reardon, et al.
Published: (2009-01-01)

Long‐Term Outcomes of Peripheral Artery Disease in Veterans: Analysis of the Peripheral Artery Disease Long‐Term Survival Study (PEARLS)
by: Saket Girotra, et al.
Published: (2025-04-01)

Characteristics of the Russian population of patients with coronary artery disease or peripheral artery disease in the XATOA registry
by: V. S. Arakelyan, et al.
Published: (2024-06-01)

Antithrombotic therapy in adults with ectatic coronary artery disease: a systematic review and network meta-analysis
by: Alireza Azarboo, et al.
Published: (2025-01-01)

Peripheral Artery Disease: Atherosclerosis, Decreased Nitric Oxide, and Vascular Arterial Stiffening
by: Melvin R. Hayden
Published: (2025-05-01)

Addressing Knowledge Gaps in Patients With High-Risk Peripheral Artery Disease
by: R. Kevin Rogers, MD, MSc, et al.
Published: (2024-10-01)

Prevalence of extracranial carotid artery disease in symptomatic peripheral artery disease and implications for long-term outcome
by: Bernhard Zierfuss, et al.
Published: (2025-12-01)

Antithrombotic use in retinal artery occlusion: A narrative review
by: Wan‐Yu Liu, et al.
Published: (2025-04-01)

Evaluation of Serum Adipokines in Peripheral Arterial Occlusive Disease
by: Claudia D. Gherman, et al.
Published: (2012-01-01)

Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease
by: Kimihiro Igari, et al.
Published: (2016-01-01)

Association of hyperleptinemia with peripheral arterial disease in hypertensive patients
by: I-Ching Huang, et al.
Published: (2017-01-01)

Racial and Socioeconomic Health Disparities in Peripheral Artery Disease
by: Victoria E. Thomas, et al.
Published: (2024-11-01)

Modern strategy of antithrombotic therapy in patients with coronary artery disease and atrial fibrillation after percutaneous coronary intervention
by: Yu. A. Karpov
Published: (2019-12-01)

Transcatheter Arterial Infusion of Autologous CD133+ Cells for Diabetic Peripheral Artery Disease
by: Xiaoping Zhang, et al.
Published: (2016-01-01)

No difference in endothelial microvasculation measured by peripheral arterial tonometry in patients with Sjögren’s disease and matched controls
by: Franziska Maria Tapken, et al.
Published: (2025-07-01)

Pharmacoeconomic study of rivaroxaban and acetylsalicylic acid combination use in patients with coronary artery disease and/or peripheral artery disease
by: N. V. Pogosova, et al.
Published: (2019-12-01)

Arterial involvement of lower limbs in peripheral artery disease - the difference between diabetics and non-diabetics
by: Tanzeela Khan, et al.
Published: (2024-02-01)

Automated Artery Detection and Stenosis Classification in CTA Using Deep Learning for Peripheral Arterial Disease
by: Ali M. O. A. Anwer, et al.
Published: (2025-01-01)

Antithrombotic Management of Atrial Fibrillation Patients Presenting with Coronary Artery Disease: A Consensus Document of the Chinese Society of Cardiology
by: Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology, et al.
Published: (2021-03-01)

Peripheral arterial disease and indicators of low-grade inflammation in patients with coronary artery disease and type 2 diabetes mellitus
by: Vadim V. Genkel, et al.
Published: (2018-08-01)

Association between cardiovascular disease and peripheral arterial disease implications for patient safety
by: Xing Wu, et al.
Published: (2025-08-01)

Revascularization Enhances Walking Dynamics in Patients with Peripheral Artery Disease
by: Farahnaz Fallahtafti, et al.
Published: (2025-05-01)

Deciphering the Role of Ferroptosis in the Pathogenesis of Peripheral Artery Disease Myopathy
by: Trevor Wilkinson, et al.
Published: (2025-05-01)

Prevalence of hypertension and peripheral arterial disease in adults in Léogâne, Haiti
by: Joel C Boggan, et al.
Published: (2019-04-01)

Influence of Peripheral Artery Disease and Statin Therapy on Apolipoprotein Profiles
by: Andrew W. Gardner, et al.
Published: (2013-01-01)

Screening for peripheral artery disease: focus on toe-brachial index
by: Krisztina Fendrik, et al.
Published: (2025-02-01)

The Pink Tax: Sex and Gender Disparities in Peripheral Artery Disease
by: Andrea Martinez, et al.
Published: (2024-02-01)